Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
9/18/2024 | $50.00 | Hold | Stifel | |
9/3/2024 | $47.00 | Market Perform | Leerink Partners | |
8/28/2024 | Neutral | Seaport Research Partners | ||
8/9/2024 | $68.00 | Buy | Deutsche Bank | |
7/25/2024 | Outperform | William Blair | ||
7/18/2024 | Buy → Hold | Needham | ||
3/13/2024 | $38.00 | Sector Perform → Outperform | RBC Capital Mkts | |
2/29/2024 | $85.00 → $55.00 | Overweight → Neutral | Piper Sandler |
4/A - Inari Medical, Inc. (0001531048) (Issuer)
4 - Inari Medical, Inc. (0001531048) (Issuer)
4 - Inari Medical, Inc. (0001531048) (Issuer)
4 - Tri Pointe Homes, Inc. (0001561680) (Issuer)
4 - Inari Medical, Inc. (0001531048) (Issuer)
Stifel initiated coverage of Inari with a rating of Hold and set a new price target of $50.00
Leerink Partners initiated coverage of Inari with a rating of Market Perform and set a new price target of $47.00
Seaport Research Partners initiated coverage of TRI Pointe Homes with a rating of Neutral
RALEIGH, N.C., July 30, 2024 (GLOBE NEWSWIRE) -- Tri Pointe Homes® (NYSE:TPH), one of the largest homebuilders in the U.S., together with its Raleigh division, today announced the development of Altis, its first 55+ lifestyle brand community on the East Coast. Located within Greenfield Communities' 550-acre Serenity development in rapidly growing Northwest Harnett County just outside Fuquay-Varina, Altis at Serenity is expected to add an additional 425 homes to the anticipated total buildout of 1,210 residences for the tranquil, planned community. Altis is projected to open in the spring of 2025 and marks the fourth community by Tri Pointe's Altis brand. "Serenity offers the per
IRVINE, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- Tri Pointe Homes® (NYSE:TPH), one of the largest homebuilders in the U.S., announced the promotion of Linda Mamet to Executive Vice President in addition to her Chief Marketing Officer role, as well as the appointment of Urmila Menon as the company's new Chief Information Officer. In her expanded capacity, Mamet will continue to oversee sales, marketing and business intelligence strategies while also collaborating closely with Menon, IT team members and functional leaders to evolve the company's technological capabilities. Mamet joined Tri Pointe Homes in 2014 as Vice President of Corporate Marketing and is a key member of the executive
Shareholders approved all agenda items and proposals of the Board of DirectorsRobert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members of the Board of DirectorsBaruch D. Kuppermann, M.D., Ph.D. and Frank G. Holz, M.D., Ph.D. appointed as members of the Scientific Advisory BoardOculis established a CHF 50 million flexible loan facility with funds and accounts managed by BlackRock ZUG, Switzerland, May 30, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (NASDAQ:OCS, XICE: OCS))) ("Oculis" or the "Company"), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced the results from its 2024 Annual General Meeting
144 - Inari Medical, Inc. (0001531048) (Subject)
10-Q - Inari Medical, Inc. (0001531048) (Filer)
8-K - Inari Medical, Inc. (0001531048) (Filer)
INCLINE VILLAGE, Nev., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Tri Pointe Homes, Inc. (NYSE:TPH), one of the largest homebuilders in the U.S., today announced the release of its 2023 sustainability report, which is available at investors.tripointehomes.com/sustainability. The report details the company's ideals and endeavors regarding important policies, commitments and actions to advance its sustainability initiatives and positively impact society. "In 2023, we continued to improve our data collection and reporting processes in connection with our carbon emissions calculations," said Doug Bauer, Tri Pointe Homes Chief Executive Officer. "We also made further investments in our LivingSma
Alterra to offer five- to six-bedroom homes on the Eastside starting from the $2 millions Eastside homebuyers will soon have the opportunity to purchase their dream home at Alterra, a 62-home neighborhood located in Newcastle, Wash., from Tri Pointe Homes, Inc. (NYSE:TPH), one of the nation's largest homebuilders. Two model homes with interiors designed and merchandized by Emmy award-winning TV host and design expert Bobby Berk are slated to open for tours starting Sept. 21. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911117497/en/Exterior of model home at Alterra. Photo credit: ImageArts Productions / Tri Pointe Homes Alt
IRVINE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that data from the PEERLESS trial will be presented by Dr. Wissam Jaber, Professor of Medicine at Emory University School of Medicine, during the Late-Breaking Clinical Trial Sessions at the 2024 Transcatheter Cardiovascular Therapeutics (TCT) Annual Scientific Symposium in Washington, D.C. The presentation will take place on October 29th. The PEERLESS trial is a prospective, randomized controlled trial ("RCT") comparing the outcomes of patients with int
SC 13G - Inari Medical, Inc. (0001531048) (Subject)
SC 13G/A - Inari Medical, Inc. (0001531048) (Subject)
SC 13G/A - Tri Pointe Homes, Inc. (0001561680) (Subject)
IRVINE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that Mitch Hill, Chief Financial Officer, will retire effective October 1, 2024 and will be succeeded by Kevin Strange, Inari's current SVP, Finance, Accounting, Strategy and Business Development. Mr. Hill has served as the CFO since 2019, and prior to that in various senior financial roles spanning over four decades. Mr. Strange joined Inari in 2020 as VP, Strategy and Business Development. Since 2023 he has served as the SVP, Finance, Accounting, Strate
IRVINE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its second quarter ended June 30, 2024. Second Quarter Financial and Recent Business Highlights Generated revenue of $146 million in Q2 of 2024, up 23% over the same quarter last year.Commenced full commercial launch of VenaCore, Inari's latest purpose-built device for the treatment of acute and chronic DVT.Cash, cash equivalents and short-term investments were $110 million as of Q2 of 2024. "Our second quarter performance was
-Home Sales Revenue of $1.1 Billion- -Homebuilding Gross Margin Percentage of 23.6%- -Diluted Earnings Per Share of $1.25- -Increased Dollar Value of Backlog to $2.0 Billion- -Reduced Debt by $450 Million- -Homebuilding Debt-to-Capital Ratio Reduced to Record Low of 22.9%- INCLINE VILLAGE, Nev., July 25, 2024 (GLOBE NEWSWIRE) -- Tri Pointe Homes, Inc. (the "Company") (NYSE:TPH) today announced results for the second quarter ended June 30, 2024. "I am pleased to report another quarter of outstanding results, driven by our focus on expanding scale and efficiencies within our existing markets while building a foundation for future growth in our new markets," said Doug Bauer, Tri Pointe Home
Wedbush analyst Jay McCanless reiterates Tri Pointe Homes (NYSE:TPH) with a Neutral and maintains $42 price target.
William Blair analyst Margaret Andrew initiates coverage on Inari Medical (NASDAQ:NARI) with a Outperform rating.